COVID-19 Treatment
FDA Rejects Emergency Use Authorization for Common and Inexpensive Antidepressant COVID-19 Treatment
2022-05-20
Kintor Pharma’s Proxalutamide Demonstrated Reduction in Hospitalization/Mortality for Patients with Mild to Moderate COVID-19 in Phase III MRCT Study
2022-04-05